Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
found that exendin-4 could reduce the resistance of prostate cancer cells to enzalutamide by targeting the PI3K/AKT/mTOR pathway, while combined use of exendin-4 and enzalutamide could significantly inhibit the growth of prostate cancer cells (210)
It can reduce the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease
Melanoma Associated with the Use of Melanotan-II[J]
GLP1 therapy is a promising way to manage weight in PWS
US$ 28.84
US$ 25.04
US$ 27.60
US$ 29.32
US$ 26.48
US$ 23.90
US$ 21.96
US$ 24.01
US$ 28.19
US$ 23.13
US$ 24.71
US$ 21.31
US$ 28.72
